Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome

Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome

Background: Lennox-Gastaut syndrome (LGS) is a severe form of childhood-onset epilepsy associated with serious injuries due to frequent and severe seizures. Of the antiepileptic drugs (AEDs) approved for LGS, clobazam is a more recent market entrant, having been approved in October 2011. Recent AED...

Full description

Bibliographic Details
Main Authors: Clément François, John M. Stern, Augustina Ogbonnaya, Tasneem Lokhandwala, Pamela Landsman-Blumberg, Amy Duhig, Vivienne Shen, Robin Tan
Format: Article
Language:English
Published: MDPI AG 2017-01-01
Series:Journal of Market Access & Health Policy
Subjects:
Lennox-Gastaut syndrome
seizure
antiepileptic drugs
clobazam
seizure-related costs
Online Access:http://dx.doi.org/10.1080/20016689.2017.1318691

Internet

http://dx.doi.org/10.1080/20016689.2017.1318691

Similar Items